C. Grohé

N. Reinmuth, J. Panse, J. Wolf, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study.

J. Atz, C. Grohé, H. Müller-Huesmann, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

LKB1 mutant in a KRAS activated adenocarcinoma of the lung associated with Peutz-Jeghers syndrome: a case report.

C. Grohé, S. Aretz, O. Zaba, 2013, Lung cancer.

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan

C. Grohé, H. Lüders, O. Zaba, 2013, BMC Pulmonary Medicine.

17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction.

R. Karas, A. Alsheikh-Ali, M. Aronovitz, 2003, Journal of the American College of Cardiology.

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation.

B. Seliger, A. Schmidt, C. Grohé, 2011, Clinical immunology.

17 (cid:1) -Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor–Cyclic Guanosine Monophosphate–Dependent Protein Kinase Pathway

P. Doevendans, L. Windt, F. Babiker, 2004 .

17&bgr;-Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway

P. Doevendans, L. D. de Windt, M. van Eickels, 2004 .

INFLUENCE OFGELSOLIN DEFICIENCYON EXCITATION CONTRACTION COUPLING INADULT MURINE CARDIOMYOCYTES

G. Nickenig, C. Grohé, K. Fink, 2015 .

Lack of gelsolin promotes perpetuation of atrial fibrillation in the mouse heart

L. Lickfett, G. Nickenig, A. Ghanem, 2009, Journal of Interventional Cardiac Electrophysiology.

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

C. Kropf-Sanchen, H. Kauczor, H. Watz, 2022, Scientific reports.

Angiotensin‐converting enzyme (ACE) inhibition attenuates insulin‐like growth factor‐I (IGF‐I) induced cardiac fibroblast proliferation

M. van Eickels, C. Grohé, Hans-Jürgen Vetter, 2000, British journal of pharmacology.

Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

C. Grohé, P. Velling, D. Skowasch, 2011, European journal of medical research.

Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats

G. Nickenig, A. Bäumer, M. van Eickels, 2001, Circulation.

[Concept for a forward-looking communication in the palliative treatment of patients with pneumological-oncological diseases prospective].

C. Grohé, O. Zaba, G. Tessmer, 2011, Pneumologie.

Diagnostik und Therapie der kardialen Sarkoidose

B. Meder, C. Grohé, D. Skowasch, 2019, Pneumologie.

Bilateral pulmonary cavitation as predominant phenotype in ANCA-associated disease.

C. Grohé, A. Juche, H. Semper, 2020, The American journal of medicine.

First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis

Yun Li, B. Wollnik, C. Grohé, 2010, Thorax.

Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function.

A. Hoeft, Se-Chan Kim, A. Ghanem, 2007 .

Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after failure on first-line immune checkpoint inhibitor combination therapy: Initial efficacy and safety results from VARGADO Cohort C.

R. Kaiser, J. Atz, C. Grohé, 2021 .

Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.

R. Kaiser, J. Atz, C. Grohé, 2019, Future oncology.

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Young Hak Kim, N. Reinmuth, A. Chiang, 2019, The Lancet.

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.

M. Tsuboi, Jie He, R. Herbst, 2020, The New England journal of medicine.

TOLL-LIKE RECEPTOR 4, NITRIC OXIDE, AND MYOCARDIAL DEPRESSION IN ENDOTOXEMIA

A. Hoeft, C. Grohé, V. Vervölgyi, 2006, Shock.

Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.

A. Hoeft, C. Grohé, K. Zacharowski, 2008, Cardiovascular research.

Myocardial injury modulates the innate immune system and changes myocardial sensitivity

A. Hoeft, Se-Chan Kim, C. Grohé, 2006, Basic Research in Cardiology.

Pneumonie

C. Grohé, 2020, DMW - Deutsche Medizinische Wochenschrift.

Pembrolizumab as First-Line Palliative Therapy in PD-L1 Overexpressing (≥ 50%) NSCLC: Real-world Results with Special Focus on PS ≥ 2, Brain Metastases, and Steroids.

C. Grah, N. Suttorp, C. Grohé, 2021, Clinical lung cancer.

Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease

A. Gillissen, C. Grohé, S. Pabst, 2009, Therapeutic advances in respiratory disease.

[Cytokines and heart failure].

A. Hoeft, C. Grohé, P. Knuefermann, 2004, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[Chronic thromboembolic pulmonary hypertension--a position paper].

H. Schäfers, W. Klepetko, C. Grohé, 2014, Deutsche medizinische Wochenschrift.

Chronisch thromboembolische pulmonale Hypertonie ( CTEPH ) 2014 Ein Positionspapier Chronic thromboembolic pulmonary hypertension – A position paper

H. Schäfers, W. Klepetko, C. Grohé, 2014 .

[Non-small-cell lung carcinoma].

S. Stier, C. Grohé, H. Vetter, 2004, Praxis.

Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism.

C. Grohé, H. Schicha, P. Theissen, 2000, American journal of physiology. Heart and circulatory physiology.

Modulation of hypertensive heart disease by estrogen

R. Karas, C. Grohé, H. Vetter, 1996, Steroids.

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo

A. Hoeft, C. Grohé, K. Zacharowski, 2007, Respiratory research.

Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility

C. Grohé, G. Baumgarten, S. Frede, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Toll-Like Receptor 2 Gene Polymorphisms Arg677Trp and Arg753Gln in Chronic Obstructive Pulmonary Disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, Lung.

Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011.

A. Günther, H. Ghofrani, F. Reichenberger, 2011, International journal of cardiology.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

A. Günther, H. Ghofrani, F. Reichenberger, 2011, Pneumologie.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

A. Günther, H. Ghofrani, F. Reichenberger, 2010, Deutsche medizinische Wochenschrift.

Atherosclerotic Vessel Changes in Sarcoidosis.

G. Nickenig, C. Grohé, D. Skowasch, 2016, Advances in experimental medicine and biology.

[Prospective evaluation of clinical parameters of AAT patients with i. v. prolastin therapy in a homecare setting].

C. Grohé, A. Wilke, 2013, Pneumologie.

[Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2010].

H. Schäfers, F. Langer, M. Hoeper, 2010, Deutsche medizinische Wochenschrift.

17β‐Estradiol regulates the expression of endothelin receptor type B in the heart

P. Doevendans, C. Grohé, H. Vetter, 2003, British journal of pharmacology.

Hormonal induction of an immediate-early gene response in myogenic cell lines--a paradigm for heart growth.

B. Wollnik, C. Grohé, L. Neyses, 1995, European heart journal.

Pulmonary 15NO uptake in interstitial lung disease.

C. Grohé, R. Gäbler, S. Brandt, 2004, Nitric oxide : biology and chemistry.

[Is hyponatremia a prognostic marker of survival for lung cancer?].

C. Grohé, O. Zaba, C. Petereit, 2011, Pneumologie.

[Cardiac sarcoidosis: diagnostic and therapeutic algorithms].

C. Tschöpe, S. Störk, C. Grohé, 2014, Pneumologie.

Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience.

G. Nickenig, C. Grohé, D. Skowasch, 2013, Advances in experimental medicine and biology.

Aktuelle Therapieansätze der Sarkoidose Current Therapeutic Approaches to Sarcoidosis

C. Grohé, D. Skowasch, C. Pizarro, 2016 .

Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats stress via AT 1 receptor overexpression,

A. Bäumer, C. Grohé, M. Böhm, 2001 .

Mitogenic signals control translation of the early growth response gene-1 in myogenic cells.

V. Sukhatme, C. Grohé, L. Neyses, 1994, Biochemical and biophysical research communications.

Pulmonary hypertension due to chronic lungdisease

A. Günther, H. Ghofrani, F. Reichenberger, 2010 .

Localablative treatment for synchronous oligometastatic lung cancer: A propensity score analysis of 180 patients.

N. Suttorp, C. Grohé, B. Schmidt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

International tailored chemotherapy adjuvant trial: ITACA trial.

C. Schumann, V. Torri, M. Papotti, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

35O_PRINVESTIGATING THE UTILITY OF CIRCULATING-FREE TUMOUR-DERIVED DNA (CTDNA) IN PLASMA FOR THE DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS IN EUROPEAN AND JAPANESE PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG CANCER (ANSCLC): ASSESS STUDY

B. Han, N. Normanno, R. McCormack, 2015 .

Hyponatremia in cancer patients: Time for a new approach.

R. Berardi, C. Grohé, S. Cascinu, 2016, Critical reviews in oncology/hematology.

SIADH: differential diagnosis and clinical management

A. Peri, R. Berardi, C. Grohé, 2016, Endocrine.

Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide.

P. Doevendans, M. van Eickels, C. Grohé, 2004, Cardiovascular research.

Parathyroid hormone‐related protein (PTHrP) signal cascade modulates myocardial dysfunction in the pressure overloaded heart

C. Grohé, R. Meyer, K. Schlüter, 2007, European journal of heart failure.

Malignant thymoma: current status of classification and multimodality treatment

D. Huhn, H. Müller-Hermelink, J. Rockstroh, 2003, Annals of Hematology.

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.

K. Stangl, Joshua Levenson, K. Aonuma, 2022, European journal of cancer.

Drug-induced myocarditis after nivolumab treatment in a patient with PDL-1-negative squamous cell carcinoma of the lung

J. Schulz-Menger, C. Grohé, M. Allewelt, 2016, Pneumologie.

Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.

H. Kreipe, C. Grohé, B. Auber, 2021, Clinical lung cancer.

[MRT versus CT in the diagnosis of pneumonias: an evaluation of a T2-weighted ultrafast turbo-spin-echo sequence (UTSE)].

C. Kuhl, C. Leutner, E. Wardelmann, 1999, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

'Tib the balance': the search for the optimal hormone replacement therapy.

C. Grohé, 2005, European heart journal.

17 b -Estradiol Attenuates the Development of Pressure-Overload Hypertrophy

H. Wellens, C. Grohé, J. Cleutjens, 2001 .

Crosstalk between the Estrogen Receptor and the Insulin-Like Growth Factor (IGF-1) Receptor. Implications for Cardiac Disease

C. Grohé, H. Vetter, R. Meyer, 1999 .

Age and hypertrophy related changes in contractile post-rest behavior and action potential properties in isolated rat myocytes

C. Grohé, R. Meyer, Q. Nguyen, 2007, AGE.

The influence of oestrogen‐deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats

P. Doevendans, C. Grohé, R. Meyer, 2005, European journal of heart failure.

Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growth

C. Grohé, L. Neyses, H. Vetter, 1997, British journal of pharmacology.

Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.

P. Doevendans, D. Lips, F. Babiker, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.

M. Tsuboi, R. Herbst, F. Shepherd, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome

C. Grohé, Fabian Leo, J. E. Bülau, 2022, Infection.

[Update 2021: Pulmonary Sequelae of COVID-19 Pneumonia].

D. Wormanns, C. Grohé, C. Meybaum, 2021, Deutsche medizinische Wochenschrift.

The cardiac cocaine connection.

C. Grohé, R. Meyer, 2003, Cardiovascular research.

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.

D. Kazdal, J. Budczies, M. Kirchner, 2022, European journal of cancer.

17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.

P. Doevendans, L. D. de Windt, M. van Eickels, 2004, Circulation.

Hodgkin’s lymphoma in a patient with Jo-1 syndrome

A. Adam, R. Büttner, S. Stier, 2007, Virchows Archiv.

TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo

A. Hoeft, C. Grohé, K. Zacharowski, 2013, Journal of Inflammation.

[Responsibilities of Weaning Centers during the COVID-19 Pandemic Outbreak - Recommendations for the Assignment of ICU Capacities in COVID-19 Patients as shown by the Berlin-Brandenburg POST-SAVE-Model].

T. Blum, S. Weber-Carstens, C. Grohé, 2020, Pneumologie.

Tracheal, laryngeal and pulmonary mucormycosis followed by organizing pneumonia in a patient with Adult Onset Still's Disease

C. Grohé, O. Kurzai, S. Kurz, 2018, Medical mycology case reports.

Cardiac myocytes and fibroblasts contain functional estrogen receptors 1

R. Karas, C. Grohé, L. Neyses, 1997, FEBS letters.

Phenotypes of organ involvement in sarcoidosis

J. Milanowski, A. Günther, M. Krawczak, 2018, European Respiratory Journal.

Caspase recruitment domain 15 gene haplotypes in sarcoidosis.

S. Cichon, M. Nöthen, T. Wienker, 2011, Tissue antigens.

17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo

P. Doevendans, C. Grohé, H. Vetter, 1999 .

Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany

K. Darwiche, K. Schmid, R. Arnold, 2014, Oncology Research and Treatment.

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.

K. Rabe, A. Günther, A. Prasse, 2021, The Lancet. Respiratory medicine.

Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance

H. Lehrach, M. Vingron, M. Odenthal, 2018, Genome Medicine.

Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.

A. Ardizzoni, C. Grohé, J. Gray, 2021, Clinical lung cancer.

Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.

F. Klauschen, D. Lenze, C. Witt, 2019, Clinical lung cancer.

Differential effects of 17[3‐estradiol on mitogen‐activated protein kinase pathways in rat cardiomyocytes

C. Grohé, H. Vetter, S. Kahlert, 1999, FEBS letters.

Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial

N. Marx, C. Sarrazin, C. Grohé, 2022, Advances in Therapy.

Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.

F. Klauschen, N. Suttorp, C. Grohé, 2020, Clinical lung cancer.

Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy

M. Tiemann, C. Grohé, L. Heukamp, 2021, Cancers.

Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.

N. Suttorp, C. Grohé, C. Furth, 2018, Lung cancer.

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial

C. Kropf-Sanchen, P. Schnabel, W. Engel-Riedel, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Sex-specific pathways in early cardiac response to pressure overload in mice

V. Regitz-Zagrosek, C. Schubert, C. Grohé, 2008, Journal of Molecular Medicine.

Lungenkarzinoms Anti-angiogenic Strategy : Therapy Optimization of Non-squamous Non-small Cell Lung Carcinoma

N. Reinmuth, C. Grohé, M. Reck, 2014 .

Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA.

M. Tsuboi, R. Herbst, Yi-long Wu, 2020 .

KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma

T. Blum, C. Grah, M. Hummel, 2021, Translational lung cancer research.

VEGF gene haplotypes are associated with sarcoidosis.

S. Cichon, M. Nöthen, T. Wienker, 2010, Chest.

K‐ras Mutation Subtypes in NSCLC and Associated Co‐occuring Mutations in Other Oncogenic Pathways

M. Hellmich, Roman K. Thomas, Y. Ko, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)].

A. Warth, W. Weichert, P. Schirmacher, 2016, Pneumologie.

PET and PET/CT with F-18 fluoride in bone metastases.

C. Grohé, H. Palmedo, S. Tasci, 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.

M. Hellmich, J. Franklin, E. Smit, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Michael Thomas, M. Schuler, C. Grohé, 2014, The oncologist.

ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study

B. Han, S. Novello, N. Normanno, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies

B. Wintersperger, H. Goebel, M. Vorgerd, 2008, Neuromuscular Disorders.

Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice.

B. Fleischmann, P. Sasse, A. Noegel, 2007, Cardiovascular research.

Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing

B. Lüderitz, C. Grohé, T. Lewalter, 2002, Basic Research in Cardiology.

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

R. Kaiser, N. Pavlakis, Keunchil Park, 2019, Future oncology.

ADAM33 gene polymorphisms in chronic obstructive pulmonary disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, European journal of medical research.

Transforming growth factor-&bgr; gene polymorphisms in different phenotypes of sarcoidosis

G. Nickenig, S. Stier, C. Grohé, 2010, European Respiratory Journal.

Systemically Administered Ligands of Toll-Like Receptor 2, -4, and -9 Induce Distinct Inflammatory Responses in the Murine Lung

C. Grohé, P. Knuefermann, G. Baumgarten, 2011, Mediators of inflammation.

Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk.

C. Gieger, M. Nöthen, K. Strauch, 2015, American journal of respiratory and critical care medicine.

Modulation of Antioxidant Enzyme Expression and Function by Estrogen

G. Nickenig, C. Grohé, M. Böhm, 2003, Circulation research.

Sporadische Lymphangioleiomyomatose (sLAM) und Tuberöse-Sklerose-Komplex (TSC) – Pulmonale Manifestationen

K. Budde, C. Grohé, S. Brakemeier, 2016, Pneumologie.

Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway*

M. van Eickels, C. Grohé, S. Kahlert, 2000, The Journal of Biological Chemistry.

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Roman K. Thomas, T. Zander, D. Seidel, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

S. Rosenkranz, M. Daemen, F. Beckers, 1998, Circulation.

Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry.

C. Kropf-Sanchen, G. Hansmann, S. Rosenkranz, 2016, European journal of internal medicine.

Toll‐like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis

A. Gillissen, C. Grohé, G. Baumgarten, 2006, Clinical and experimental immunology.

Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?

R. Kaiser, S. Novello, C. Grohé, 2020, Lung cancer.

TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo

A. Hoeft, C. Grohé, K. Zacharowski, 2013, Journal of Inflammation.

Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.

Michael Thomas, P. Schnabel, T. Muley, 2018, Lung cancer.

Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study

J. Verbalis, A. Greenberg, C. Grohé, 2017, Supportive Care in Cancer.

Estrogenic hormone action in the heart: regulatory network and function.

P. Doevendans, L. D. de Windt, M. van Eickels, 2002, Cardiovascular research.

Estrogen Receptor &bgr; Protects the Murine Heart Against Left Ventricular Hypertrophy

P. Doevendans, D. Lips, F. Babiker, 2006 .

, Protects the Murine Heart Against Left Ventricular Hypertrophy β Estrogen Receptor

P. Doevendans, D. Lips, F. Babiker, 2006 .

Estrogen Modulates AT 1 Receptor Gene Expression In Vitro and In Vivo Brief Rapid Communication

S. Rosenkranz, M. Daemen, F. Beckers, 1998 .

[Chronic thromboembolic pulmonary hypertension--a position paper].

H. Schäfers, W. Klepetko, C. Grohé, 2014, Deutsche medizinische Wochenschrift.

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease

A. Gillissen, G. Nickenig, C. Grohé, 2009, European journal of medical research.

R. Holle, C. Kropf-Sanchen, H. Watz, 2020, BMC Pulmonary Medicine.

A. Prasse, T. Welte, F. Herth, 2017, Respiratory Research.

Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population.

R. Fimmers, H. Schild, A. Goebel, 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[German guideline for diagnosis and management of idiopathic pulmonary fibrosis].

H. Sitter, A. Günther, A. Prasse, 2013, Pneumologie.

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET

H. Kauczor, H. Watz, J. Virchow, 2020, Scientific Reports.

17&bgr;-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy

H. Wellens, M. van Eickels, C. Grohé, 2001, Circulation.

Activation of estrogen receptor β is a prerequisite for estrogen‐dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes

B. Katzenellenbogen, R. Karas, J. Katzenellenbogen, 2001, FEBS letters.

Rapid modulation of L‐type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea‐pig and rat

R. Surges, C. Grohé, R. Meyer, 1998, Experimental physiology.

Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011.

Matthias Schmidt, Jürgen Behr, Frank Langer, 2011, International journal of cardiology.

ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellsch

A. Warth, W. Weichert, P. Schirmacher, 2017, Lung cancer.

Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study

G. Nickenig, C. Grohé, D. Skowasch, 2012, PloS one.

Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.

C. Grohé, C. Finke, A. Aigner, 2021, JAMA oncology.

Sex hormones and arrhythmia in myocardial ischemia

C. Grohé, T. Korte, 2006, British journal of pharmacology.

Female Mice Lacking Estrogen Receptor β Display Prolonged Ventricular Repolarization and Reduced Ventricular Automaticity After Myocardial Infarction

P. Chambon, A. Krust, H. Drexler, 2005, Circulation.

Effects of estrogen on skeletal myoblast growth.

R. Karas, C. Grohé, L. Neyses, 1997, Biochemical and biophysical research communications.

The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report

M. Tsuboi, F. de Marinis, M. Tiseo, 2022, ESMO open.

Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis

M. Essler, G. Nickenig, C. Grohé, 2017, ESC heart failure.

LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA

F. de Marinis, C. Grohé, Y. Wu, 2022, Annals of Oncology.

[Extrinsic allergic alveolitis].

C. Grohé, H. Vetter, B. Weisser, 2004, Praxis.

Toll-like receptor-9 polymorphisms in sarcoidosis and chronic obstructive pulmonary disease.

Georg Nickenig, A. Gillissen, G. Nickenig, 2013, Advances in experimental medicine and biology.

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.

N. Reinmuth, I. Horváth, K. Syrigos, 2022, The Lancet. Respiratory medicine.

Role of Toll‐like receptor 4 for the pathogenesis of acute lung injury in Gram‐negative sepsis

A. Hoeft, C. Putensen, C. Grohé, 2006, European journal of anaesthesiology.

Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development.

A. Ghanem, C. Grohé, T. Lewalter, 2003, American journal of physiology. Heart and circulatory physiology.

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

M. Tsuboi, R. Herbst, F. Shepherd, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyponatraemia--SIADH in lung cancer diagnostic and treatment algorithms.

C. Grohé, V. Burst, R. Berardi, 2015, Critical reviews in oncology/hematology.

Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry

A. Prasse, T. Welte, J. Behr, 2017 .

[Diabetes insipidus due to neurosarcoidosis].

C. Grohé, D. Skowasch, S. Pabst, 2011, Pneumologie.

Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study.

L. Sequist, E. Smit, Gregory Riely, 2022, European journal of cancer.

PL02.03 Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

L. Paz-Ares, T. Ciuleanu, C. Grohé, 2021, Journal of Thoracic Oncology.

Hyponatremia in Oncology Patients.

C. Grohé, 2019, Frontiers of hormone research.

Receptor Gene Expression In Vitro and In Vivo 1 Estrogen Modulates

M. Daemen, F. Beckers, G. Nickenig, 1998 .

1096O Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results from the phase III SPINET study

E. Baudin, D. Hörsch, C. Grohé, 2021, Annals of Oncology.

A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1

C. Gieger, H. Wichmann, P. Rosenstiel, 2012 .

Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis

P. Rosenstiel, A. Franke, M. Nothnagel, 2012, European Respiratory Journal.

M. Tsuboi, R. Herbst, Yi-long Wu, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prevalence of sarcoidosis-associated pulmonary hypertension: cumulative analysis of two PULSAR studies

C. Grohé, D. Skowasch, S. Pabst, 2020, European Respiratory Journal.

Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO

R. Kaiser, S. Krüger, J. Atz, 2021, Translational Lung Cancer Research.

Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome

C. Grohé, Fabian Leo, J. E. Bülau, 2022, Infection.

Use of Anticholinergic and Antifungal Pharmacotherapy for the Management of Bronchorrhea in a Patient With BRAF-mutated Adenocarcinoma of the Lung.

C. Grohé, H. Semper, Fabian Leo, 2019, Journal of pain and symptom management.

Efficacy and safety of nivolumab in routine NSCLC treatment – an observational study in 5 lung cancer centers in Berlin, Germany

T. Blum, C. Grah, C. Grohé, 2017 .

17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo.

P. Doevendans, C. Grohé, H. Vetter, 1999, Cardiovascular research.

Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)

C. Schade-Brittinger, K. Rabe, A. Prasse, 2019, Idiopathic interstitial pneumonias.

Nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated efficacy and safety results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455).

R. Kaiser, J. Atz, C. Grohé, 2020 .

Preliminary Phase II results of a multicenter, open-label study of nazartinib (EGF816) in adult patients with treatment-naïve EGFR-mutant non-small cell lung cancer (NSCLC).

L. Sequist, E. Smit, E. Felip, 2018 .

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry

A. Prasse, J. Behr, M. Kreuter, 2016 .

Initial experience with lung-MRI at 3.0T: Comparison with CT and clinical data in the evaluation of interstitial lung disease activity.

G Lutterbey, J. Gieseke, H. Schild, 2007, European journal of radiology.

Gender associated Differences in Patients with IPF based on the Analysis of the INSIGHTS-IPF Registry Data

A. Prasse, M. Kreuter, S. Gläser, 2017 .

ADAM 33 GENE POLYMORPHISMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

A. Gillissen, G. Nickenig, C. Grohé, 2022 .

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.

F. Cappuzzo, D. Gandara, D. Planchard, 2015, The Lancet. Oncology.

Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes.